Post-Hong Kong: Human Genome Editing’s Brave New World
The National Academy of Medicine and the CSIS Commission on Strengthening America’s Health Security will host a conversation on the unfolding debate as to whether human germline genome editing should be permitted, the types of applications which might be appropriate, the standards and criteria that should be followed, and what regulatory or governance framework is needed.
Jeffrey Kahn, Andreas C. Dracopoulos Director of the Berman Institute of Bioethics, will participate as a panelist.
Other panelists include:
Dr. Victor Dzau
President, National Academy of Medicine
Senior Vice President, Corporate Affairs, Editas Medicine
Senior Director, Committee on Science, Technology, and Law, The National Academies of Sciences, Engineering, and Medicine
J. Stephen Morrison
Senior Vice President and Director, CSIS Global Health Policy Center